The mechanisms by which Yiqi Huoxue compound treats pulmonary inflammation and fibrosis in scleroderma: Based on bioinformatics and network pharmacology

• Main Authors: Menghua HU (Author), Qiaorui TAN (Author), Weilin PU (Author), Min DU (Author), Wenzhen TU (Author), Dayan SUN (Author), Jingyi YANG (Author), Yifei GU (Author), Jiucun WANG (Author), Xiangzhen KONG (Author)
• Format: Book
• Published: editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective To identify the effective components and key molecules of Yiqi Huoxu compound(YQHX) in the treatment of pulmonary inflammation and fibrosis in scleroderma, providing basis for the development of drug targets for scleroderma. Methods A mouse model of pulmonary fibrosis was established by a...